John R. Moore, General Counsel at Edgewise Therapeutics, Inc. (EWTX), sold 18,464 shares at $9.31 ($172K) on 2022-08-03, disclosed to the SEC on 2022-08-05.
Open-market sale of $172k EWTX by General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.31 | 9,232 | $86K | 50.0% |
| 2 | $9.31 | 9,232 | $86K | 50.0% |
| Total | $9.31 avg | 18,464 | $172K | 100% |
| Filing → |
| EWTX | SELL | 2025-05-07 | $32K | — | Filing → |
| EWTX | SELL | 2024-09-24 | $2.6M | — | Filing → |
| EWTX | SELL | 2024-05-03 | $37K | — | Filing → |